Premium
Safety and efficacy of pegylated interferon and ribavirin in adolescents with human immunodeficiency virus and hepatitis C virus acquired perinatally
Author(s) -
Rosso Raffaella,
Di Biagio Antonio,
Mikulska Malgorzata,
Nicco Elena,
Bernardini Claudia,
Viscoli Claudio
Publication year - 2010
Publication title -
journal of medical virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.782
H-Index - 121
eISSN - 1096-9071
pISSN - 0146-6615
DOI - 10.1002/jmv.21802
Subject(s) - ribavirin , pegylated interferon , virology , hepatitis c virus , medicine , interferon , virus , hepatitis c , viral disease , human immunodeficiency virus (hiv) , immunology
Abstract Limited evidence is available currently regarding the efficacy and safety of pegylated interferon (PEG‐IFN) and ribavirin in patients co‐infected perinatally with human immunodeficiency virus (HIV) and hepatitis C virus (HCV). No information is available on whether or not these patients should be treated earlier for infection with HCV. This report describes four patients with HIV and HCV co‐infection acquired perinatally, who were treated with PEG‐IFN and ribavirin for chronic viral hepatitis caused by HCV. J. Med. Virol. 82: 1110–1114, 2010. © 2010 Wiley‐Liss, Inc.